Global WholeHealth Partners Corporation (GWHP)
USD 0.0
(-90.0%)
USD 0.0
(-90.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | - USD | -100.0% |
| 2022 | 692.13 Thousand USD | 427.92% |
| 2021 | 131.1 Thousand USD | -31.29% |
| 2020 | 190.81 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2014 | 143 Thousand USD | 28.83% |
| 2013 | 111 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 FY | - USD | -100.0% |
| 2022 Q4 | 692.13 Thousand USD | -46.18% |
| 2022 FY | 692.13 Thousand USD | 427.92% |
| 2022 Q3 | 1.28 Million USD | -7.26% |
| 2022 Q2 | 1.38 Million USD | 596.15% |
| 2022 Q1 | 199.21 Thousand USD | 51.95% |
| 2021 Q3 | 254.23 Thousand USD | 60.12% |
| 2021 Q1 | 185.94 Thousand USD | -2.55% |
| 2021 Q4 | 131.1 Thousand USD | -48.43% |
| 2021 Q2 | 158.78 Thousand USD | -14.61% |
| 2021 FY | 131.1 Thousand USD | -31.29% |
| 2020 Q3 | 62.87 Thousand USD | 0.0% |
| 2020 FY | 190.81 Thousand USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q4 | 190.81 Thousand USD | 203.48% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2015 Q1 | 138 Thousand USD | -3.5% |
| 2015 Q2 | 138 Thousand USD | 0.0% |
| 2015 Q3 | - USD | -100.0% |
| 2014 Q1 | 116 Thousand USD | 0.0% |
| 2014 Q2 | 116 Thousand USD | 0.0% |
| 2014 Q3 | 116 Thousand USD | 0.0% |
| 2014 Q4 | 143 Thousand USD | 23.28% |
| 2014 FY | 143 Thousand USD | 28.83% |
| 2013 FY | 111 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | 100.0% |
| Arrayit Corporation | 1.07 Million USD | 100.0% |
| Atlantic International Corp. | 2.93 Million USD | 100.0% |
| Biocept, Inc. | 12.1 Million USD | 100.0% |
| Bioqual, Inc. | 3.58 Million USD | 100.0% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | 100.0% |
| DermTech, Inc. | 54.39 Million USD | 100.0% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 100.0% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 100.0% |
| iMD Companies, Inc. | 1.12 Million USD | 100.0% |
| IDenta Corp. | 789.14 Thousand USD | 100.0% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 100.0% |
| Integrative Health Technologies, Inc. | - USD | NaN% |
| InVitro International | 43.84 Thousand USD | 100.0% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 100.0% |
| Many Bright Ideas Technologies Inc. | - USD | NaN% |
| Medical Imaging Corp. | 3.82 Million USD | 100.0% |
| NovelStem International Corp. | 3.57 Million USD | 100.0% |
| Optigenex Inc. | 8.94 Million USD | 100.0% |
| PharmChem, Inc. | 77.35 Thousand USD | 100.0% |
| Proteome Sciences plc | 17.15 Million USD | 100.0% |
| Response Genetics, Inc | 6.37 Million USD | 100.0% |
| Rennova Health, Inc. | 15.32 Million USD | 100.0% |
| RushNet, Inc. | 4.82 Million USD | 100.0% |
| ScreenPro Security Inc. | 207.03 Thousand USD | 100.0% |
| Stella Diagnostics Inc. | 6.2 Million USD | 100.0% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | 100.0% |
| Todos Medical Ltd. | 38.34 Million USD | 100.0% |